COMPANY PROFILE

Seventh Sense Biosystems

Explore full profile

Simplifying blood sampling and testing

Medford, United StatesFounded 2007Biotech & Life Sciences

Valuation $100–250M Last recorded · 2021

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Seventh Sense Biosystems

YourBio Health is a leader in at-home pediatric healthcare innovation, specializing in virtually painless blood collection using patented microneedle technology. The company serves wellness clients, healthcare providers, and organizations conducting decentralized clinical trials. Operating in the medical device and healthcare sectors, YourBio Health's business model focuses on selling its innovative blood collection devices and related services. Revenue is generated through direct sales to healthcare providers and partnerships with organizations conducting clinical trials. The company aims to improve patient compliance and experience while maintaining high venous concordance. YourBio Health's mission is to revolutionize blood collection, making it less painful and more accessible.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2007
Headquarters: Medford, United States
Employees: 19
Open positions: None listed
Dealroom signal: 62.1/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Testing, Biotechnology, Health Diagnostics, Spinout, Tech for Patients, Biotech and Pharma, medical testing, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

10 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Dec 2025	$0	—	Hims and Hers Health	↗
LATE VCOther financing	Sep 2021	$21M	$84M	Newpath Partners · Flagship Pioneering	—

Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Growth signals

Seventh Sense Biosystems website traffic

Latest recorded traffic for Seventh Sense Biosystems is 100 monthly website visits, down 96.4% over the last three months. Seventh Sense Biosystems's team declined 40.6% over the past year.

Latest monthly visits100 3-month web change-96.4% 1-year team growth-40.6%

Monthly website visitsApr 2016–May 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
AFAfyniaEndometriosis tests	Hamilton, Canada	Operational	8	$7M	$20M
IIIQuity, Inc.IQuity is a research organization developing the next generation of blood-based, genomic tests to detect and monitor autoimmune disease	Nashville, United States	Operational
GEGemmaCertGemmaCert is developing a non-destructive and noninvasive analytical cannabis-testing technology for professional and home use	Ra'anana, Israel	Operational
MTMetabolomic TechnologiesCommitted to developing non-invasive in-vitro diagnostics to meet patients' greatest unmet needs	Edmonton, Canada	Operational
2323MofangGenetics testing and analyzing Startup Based In China	Chengdu, China	Operational
CTCARsgen TherapeuticsA leading immunotherapy company focused on the development of new chimeric antigen receptor	Xuhui District, China	Operational
ADAmoy DiagnosticAmoy Diagnostic focuses on molecular diagnostics for oncology precision medicine	Dongcheng District, China	Operational
GDGroup K DiagnosticsDeveloping a point-of-care diagnostic device that leverages paper-based microfluidics technology to reduce cost and time of testing for over 40 diseases	Philadelphia, United States	Operational